Results
hypoglycemia, FM
HYPOGLYCEMIA, DIABETIC KETOACIDOSIS
Forty-six participants (mean age: 35.6 years, range: 21-56) agreed to participate in the educational program and at the end of the program 26 of them refused to switch to SAP therapy and continued with MDI therapy, while 20 switched to SAP.No participants in either group experienced severe hypoglycemia or diabetic ketoacidosis.People who switched to SAP used the following SAP devices: 10 Medtronic 670/780, 6 Omnipod, 3 Tandem t:slim, and 1 Accu-Chek Solo. Additionally, 13 devices had a closed loop system, and 7 had a patch pump. None of the participants were on enteral nutrition or were taking energy supplements.
Baseline characteristics between treatment groups before and after weighting.BMI, Body mass index; FM, Fat mass; FFM, Fat-free mass; IU, International units; MDI, Multiple daily injection; ppFEV1, percent of predicted forced expiratory volume in one second; SAP, Sensor augmented pump; SMD, Standardized mean difference; TAR, Time above range; TBR, Time below range; TIR, Time in range.


All participants completed the last study visit, though HbA1c was not measured in one patient in the MDI group.In the SAP group, HbA1c decreased after 6 months from baseline and this reduction persisted over the study period, while it remained substantially unchanged in the MDI group (Model-based means of HbA1c Changes in study outcomes over 24 months among patients in the MDI group and those undergoing SAP therapy, along with the corresponding between-group differences.BMI, Body mass index; CI, Confidence interval; FFM, Fat-free mass; FM, Fat mass; ppFEV1, percent of predicted forced expiratory volume in one second; TAR, Time above range; TBR, Time below range; TIR, Time in range.

In people who switched to SAP, mean glucose from CGM significantly decreased and TIR increased, while no significant changes were observed in participants in the MDI group (People who switched to SAP also had a significant increase in body weight, BMI and fat-free mass and a reduction in fat mass (Model-based means of BMI 